CJC-1295 (with DAC)
A longer-acting copy of the brain signal for growth hormone, changed so it sticks to a blood protein and stays active for days.
Learn about CJC-1295 (with DAC)Also known as: Modified GRF 1-29
A short-acting copy of the brain signal that tells the pituitary gland to release growth hormone in short bursts.
CJC-1295 without DAC, also called Modified GRF 1-29, is a lab-made copy of growth hormone-releasing hormone. The body clears it quickly, so its signal is short.
The natural brain signal for growth hormone breaks down within minutes. Researchers trimmed it to its first 29 amino acids and made small changes so it would survive longer, and that is Modified GRF 1-29.
The naming is genuinely confusing. CJC-1295 originally referred to the long-acting version. The short-acting one picked up the same name over time, so clinics add without DAC to tell them apart.
It is usually named alongside ipamorelin, because the two reach the pituitary gland through different receptors.
The pituitary gland releases growth hormone in bursts, and the brain's releasing hormone is what triggers each burst.
This peptide copies that trigger. It binds the same receptors on the pituitary and prompts a burst of the gland's own growth hormone.
It clears within a few hours, so the signal comes and goes. That short pattern is closer to how the body does it naturally than a signal that stays on for days.
Growth hormone then raises IGF-1, and that pair is what the muscle, recovery, and body-composition claims are built on.
Adults focused on lean muscle and recovery who prefer a short, pulse-like signal
People weighing the short-acting and long-acting CJC-1295 forms against each other
Adults looking at body composition through the growth hormone system
People trying to understand what the CJC-1295 / Ipamorelin name actually refers to
How this compound compares to related options in the wellness landscape.
The long-acting version, which attaches to a blood protein and stays active for days rather than hours.
Reaches a different receptor in the same gland, which is why the two are often named together.
Other compounds that support overlapping wellness goals.
A longer-acting copy of the brain signal for growth hormone, changed so it sticks to a blood protein and stays active for days.
Learn about CJC-1295 (with DAC)A lab-made peptide that nudges the pituitary gland to release growth hormone in its normal on-and-off pattern.
Learn about IpamorelinA named pairing of two growth hormone peptides that reach the pituitary gland through two different doors.
Learn about CJC-1295 / IpamorelinA prescription copy of the brain signal for growth hormone, approved to reduce excess belly fat in adults living with HIV.
Learn about TesamorelinCJC-1295 without DAC is not FDA-approved. That means the FDA has not reviewed it for safety or effectiveness for the uses described here. Published human data is limited to small early studies.
Peptides in our shop are sourced from US-licensed manufacturers.
CJC-1295 without DAC is not FDA-approved, and its status under pharmacy compounding rules is still being decided.
Raising growth hormone can affect blood sugar and can cause fluid retention or joint aches.
The short-acting and long-acting forms are not interchangeable. How long the signal lasts is the whole difference.
See current pricing and availability for CJC-1295 (without DAC) in our shop. If a medical evaluation is needed, a licensed provider guides you through it.
Individual results vary. General information on this site is not a substitute for professional medical advice.